Announcements Trials

Browse Landscape

Phase

Phase 2 13 Phase 1 10 Phase 1/2 6 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Immunoglobulin Light-chain Amyloidosis 1

Interventions

Cisplatin 294 Radiotherapy 230 Fluorouracil 201 Cyclophosphamide 191 Capecitabine 182 Docetaxel 167 Gemcitabine 165 Oxaliplatin 162 Carboplatin 161 Paclitaxel 152 Leucovorin 122 Drug Therapy 119 Dexamethasone 119 Doxorubicin 112 Etoposide 99 Bevacizumab 91 Cytarabine 87 Vincristine 83 Irinotecan 81 Rituximab 77 Epirubicin 71 Prednisone 65 Radiosurgery 63 Methotrexate 62 Surgical Procedures, Operative 61 Radiation 60 Radiotherapy, Intensity-Modulated 57 Neoadjuvant Therapy 53 Lenalidomide 52 Letrozole 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × Blood Component Removal × Clear all

NCT02489500 2018-09-10

VelRand

Boston Medical Center

Phase 3 Terminated

3 enrolled 11 charts

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡